ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	7 December 2015
Main ID:	NCT01697254
Date of registration:	28/09/2012
Prospective Registration:	No
Primary sponsor:	Duke University
Public title:	The CARRA Registry CARRA Registry
Scientific title:	The CARRA Registry
Date of first enrolment:	August 2009
Target sample size:	9587
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT01697254
Study type:	Observational [Patient Registry]
Study design:	Observational Model: Cohort, Time Perspective: Prospective
Phase:	N/A

Countries of recruitment
United States

Contacts

Name:	Norman T Illowite, MD
Address:
Telephone:
Email:
Affiliation:	Children's Hospital at Montefiore

Name:	Laura Schanberg, MD
Address:
Telephone:
Email:
Affiliation:	Duke University

Name:	Christy Sandborg, MD
Address:
Telephone:
Email:
Affiliation:	Lucile Salter Packard Children's Hospital/Stanford University School of Medicine

Name:	Carol Wallace, MD
Address:
Telephone:
Email:
Affiliation:	Seattle Children's Hospital/ University of Washington School of Medicine

Key inclusion & exclusion criteria

Inclusion Criteria:

- Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 18
years for all other rheumatic diseases

- Subject has been diagnosed with a defined pediatric rheumatic disease including:
Mixed Connective Tissue Disease (MCTD), Systemic Lupus Erythematosus (SLE), Primary
Sjögren's Syndrome (pSS), Systemic Sclerosis (SS), Juvenile Dermatomyositis (JDM),
Localized Scleroderma (LS), Juvenile Idiopathic Arthritis (JIA), Vasculitis, Sarcoid,
Auto-inflammatory Diseases, Idiopathic Uveitis (IU), and Juvenile Primary
Fibromyalgia Syndrome (JPFS).

- Subject (and/or parent/legal guardian when required) is able to provide written
informed consent and willing to comply with study procedures.

Exclusion Criteria:

- None

Age minimum: N/A
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Idiopathic Uveitis Idiopathic

Mixed Connective Tissue Disease

Juvenile Idiopathic Arthritis

Juvenile Dermatomyositis

Localized Scleroderma

Systemic Sclerosis

Vasculitis

Sarcoid

Auto-inflammatory Disease

Fibromyalgia, Primary

Systemic Lupus Erythematosus

Juvenile Ankylosing Spondylitis

Intervention(s)

Primary Outcome(s)

Enrolled Subjects [Time Frame: baseline]

Secondary Outcome(s)

Secondary ID(s)

1RC2AE058934-01

Pro00018979

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Cure JM Foundation

Lupus Foundation of America

National Institutes of Health (NIH)

Arthritis Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.